Page 14 - Prima System News Today

Pixium Vision appoints experienced international financial executive Offer Nonhoff as CFO Paris, France, June 25 2021 – 07.00 CET– Pixium Vision SA...

Investegate announcements from Pixium Vision, Pixium Vision announces business update and key upcoming milestones to deliver on its business plan

Pixium Vision receives HealthTech Award for Prima System at the MedTech Forum Best Product/Deal for its bionic vision Prima System. The award, presented at the MedTech Forum 2021, recognizes the most promising game changers developing emerging technologies for healthcare in Europe, and is organized by the NOBEL Projectand hosted by the MedTech Forum. " HealthTech Lloyd Diamond, Chief Executive Officer of Pixium Vision . "The Prima System has demonstrated its potential to make a significant imp...

Lloyd Diamond, Chief Executive Officer of Pixium Vision . “The Prima System has demonstrated its potential to make a significant improvement to the quality of life of patients with dry AMD and this award recognizes its capacity to improve vision. I would like to thank the entire Pixium Vision team and our collaborators for their dedication in developing the Prima System and progressing it through clinical trials and towards patients in desperate need of treatment.” The Prima System, a pho...

Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. Paris, 16 April 2021 - 6:00 p.m. CEST - Pixium Vision (Euronext Growth Paris - FR0011950641 - ALPIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, ann...

Cash position at 31 December 2020: €10.6 million Cash runway to end of 2021 PRIMAvera European pivotal study of Prima System initiated in Q4 2020 Paris, 19 February 2021 – 7.00 a.m. CET - Pixium Vision (FR0011950641 - PIX), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independently, announces its financial results for 2020. The 2020 financial statements were approved by Pixium Visions Board of...

Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market Aims to create a global leader with potential to treat nearly all forms of blindness Combined company to trade on Nasdaq and benefit from business and development synergies in the U.S. and Europe Transaction provides broader access to financing sources to enable the combined company to accelerate the development and commercialization of its products Pixium Visi...

Pixium Vision Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market Aims to create a global leader with potential to treat nearly all forms of b...